I'm not opining one way or the other about the propriety of the "Chevron" decision, but rather posting about its consequences with respect to the FDA, Medicare, and biotech investing in general.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”